Corcept Therapeutics, Inc. (CORT)

37.04 +0.69 (+1.90%) USD  |  NASDAQ  |  Jan 14, 16:00
36.71 -0.33 (-0.89%) After-Hours: 20:00
More

Corcept Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for CORT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Axsome Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
United Therapeutics Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade